The patent badge is an abbreviated version of the USPTO patent document. The patent badge does contain a link to the full patent document.

The patent badge is an abbreviated version of the USPTO patent document. The patent badge covers the following: Patent number, Date patent was issued, Date patent was filed, Title of the patent, Applicant, Inventor, Assignee, Attorney firm, Primary examiner, Assistant examiner, CPCs, and Abstract. The patent badge does contain a link to the full patent document (in Adobe Acrobat format, aka pdf). To download or print any patent click here.

Date of Patent:
Jan. 25, 2022

Filed:

Feb. 26, 2016
Applicants:

Université DE Bretagne Occidentale—ubo, Brest, FR;

Inserm, Paris, FR;

Centre Hospitalier Régional ET Universitaire DE Brest, Brest, FR;

Inventors:

Yves Renaudineau, Brest, FR;

Olivier Mignen, Logonna Daoulas, FR;

Marjolaine Debant, Brest, FR;

Christelle Le Dantec, Plougasnou, FR;

Jacques Olivier Pers, Brest, FR;

Attorney:
Primary Examiner:
Int. Cl.
CPC ...
A61K 33/00 (2006.01); G01N 33/564 (2006.01); G01N 33/574 (2006.01); G01N 33/68 (2006.01);
U.S. Cl.
CPC ...
G01N 33/564 (2013.01); G01N 33/57426 (2013.01); G01N 33/6893 (2013.01); G01N 33/574 (2013.01); G01N 2800/104 (2013.01); G01N 2800/52 (2013.01); G01N 2800/7028 (2013.01);
Abstract

Some embodiments are directed to a process for the diagnosis of systemic lupus erythematosus (SLE) and/or of chronic lymphoid leukaemia (CLL) of a subject who may be suffering therefrom, comprising the in vitro detection of the expression of the fraction of the STIM1 protein located at the cell plasma membrane in a biological sample from human and mice. Some other embodiments are directed to a process for predicting the progression and/or monitoring the progression of CLL and/or of SLE, comprising the in vitro detection of the expression of the fraction of the STIM1 protein located at the cell plasma membrane.


Find Patent Forward Citations

Loading…